The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Live Attenuated Vaccines Market Outlook 2025
Synopsis
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
The global Live Attenuated Vaccines market was valued at US$ 25940 million in 2020 and is expected to reach US$ 40390 million by the end of 2027, growing at a CAGR of 6.1% during 2021-2027.
This report focuses on Live Attenuated Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Live Attenuated Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Live Attenuated Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Bacterial
Viral
Segment by Application
Hospitals
Clinics
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson & Johnson
CSL
Sanofi
Serum Institute Of India
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
The global Live Attenuated Vaccines market was valued at US$ 25940 million in 2020 and is expected to reach US$ 40390 million by the end of 2027, growing at a CAGR of 6.1% during 2021-2027.
This report focuses on Live Attenuated Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Live Attenuated Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Live Attenuated Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Bacterial
Viral
Segment by Application
Hospitals
Clinics
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson & Johnson
CSL
Sanofi
Serum Institute Of India
Index1 Live Attenuated Vaccines Market Overview
1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Live Attenuated Vaccines Segment by Type
1.2.1 Global Live Attenuated Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Bacterial
1.2.3 Viral
1.3 Live Attenuated Vaccines Segment by Application
1.3.1 Global Live Attenuated Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Live Attenuated Vaccines Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Vaccines Revenue 2016-2027
1.4.2 Global Live Attenuated Vaccines Sales 2016-2027
1.4.3 Live Attenuated Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Live Attenuated Vaccines Market Competition by Manufacturers
2.1 Global Live Attenuated Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Live Attenuated Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Live Attenuated Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Live Attenuated Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Live Attenuated Vaccines Market Competitive Situation and Trends
2.5.1 Live Attenuated Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Live Attenuated Vaccines Players Market Share by Revenue
2.5.3 Global Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Live Attenuated Vaccines Retrospective Market Scenario by Region
3.1 Global Live Attenuated Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Live Attenuated Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Live Attenuated Vaccines Market Facts & Figures by Country
3.3.1 North America Live Attenuated Vaccines Sales by Country
3.3.2 North America Live Attenuated Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Live Attenuated Vaccines Market Facts & Figures by Country
3.4.1 Europe Live Attenuated Vaccines Sales by Country
3.4.2 Europe Live Attenuated Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Live Attenuated Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Live Attenuated Vaccines Sales by Region
3.5.2 Asia Pacific Live Attenuated Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Live Attenuated Vaccines Market Facts & Figures by Country
3.6.1 Latin America Live Attenuated Vaccines Sales by Country
3.6.2 Latin America Live Attenuated Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Live Attenuated Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Live Attenuated Vaccines Sales by Country
3.7.2 Middle East and Africa Live Attenuated Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Live Attenuated Vaccines Historic Market Analysis by Type
4.1 Global Live Attenuated Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Live Attenuated Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Live Attenuated Vaccines Price by Type (2016-2021)
5 Global Live Attenuated Vaccines Historic Market Analysis by Application
5.1 Global Live Attenuated Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Live Attenuated Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Live Attenuated Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Live Attenuated Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Live Attenuated Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Live Attenuated Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Astellas Pharma
6.4.1 Astellas Pharma Corporation Information
6.4.2 Astellas Pharma Description and Business Overview
6.4.3 Astellas Pharma Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astellas Pharma Live Attenuated Vaccines Product Portfolio
6.4.5 Astellas Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Johnson & Johnson Live Attenuated Vaccines Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 CSL Live Attenuated Vaccines Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Live Attenuated Vaccines Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Serum Institute Of India
6.8.1 Serum Institute Of India Corporation Information
6.8.2 Serum Institute Of India Description and Business Overview
6.8.3 Serum Institute Of India Live Attenuated Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Serum Institute Of India Live Attenuated Vaccines Product Portfolio
6.8.5 Serum Institute Of India Recent Developments/Updates
7 Live Attenuated Vaccines Manufacturing Cost Analysis
7.1 Live Attenuated Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Live Attenuated Vaccines
7.4 Live Attenuated Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Live Attenuated Vaccines Distributors List
8.3 Live Attenuated Vaccines Customers
9 Live Attenuated Vaccines Market Dynamics
9.1 Live Attenuated Vaccines Industry Trends
9.2 Live Attenuated Vaccines Growth Drivers
9.3 Live Attenuated Vaccines Market Challenges
9.4 Live Attenuated Vaccines Market Restraints
10 Global Market Forecast
10.1 Live Attenuated Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Live Attenuated Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Live Attenuated Vaccines by Type (2022-2027)
10.2 Live Attenuated Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Live Attenuated Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Live Attenuated Vaccines by Application (2022-2027)
10.3 Live Attenuated Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Live Attenuated Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Live Attenuated Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Live Attenuated Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Live Attenuated Vaccines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Live Attenuated Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Live Attenuated Vaccines Covered in This Study
Table 5. Global Live Attenuated Vaccines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Live Attenuated Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Live Attenuated Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Live Attenuated Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Live Attenuated Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Live Attenuated Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Live Attenuated Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Live Attenuated Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Attenuated Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Live Attenuated Vaccines Sales by Region (2016-2021) & (K Units)
Table 16. Global Live Attenuated Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Live Attenuated Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Live Attenuated Vaccines Sales by Country (2016-2021) & (K Units)
Table 19. North America Live Attenuated Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Live Attenuated Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Live Attenuated Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Live Attenuated Vaccines Sales by Country (2016-2021) & (K Units)
Table 23. Europe Live Attenuated Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Live Attenuated Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Live Attenuated Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Live Attenuated Vaccines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Live Attenuated Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Live Attenuated Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Live Attenuated Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Live Attenuated Vaccines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Live Attenuated Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Live Attenuated Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Live Attenuated Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Live Attenuated Vaccines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Live Attenuated Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Live Attenuated Vaccines Sales (K Units) by Type (2016-2021)
Table 39. Global Live Attenuated Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Live Attenuated Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Live Attenuated Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Live Attenuated Vaccines Price (USD/Unit) by Type (2016-2021)
Table 43. Global Live Attenuated Vaccines Sales (K Units) by Application (2016-2021)
Table 44. Global Live Attenuated Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Live Attenuated Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Live Attenuated Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Live Attenuated Vaccines Price (USD/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Live Attenuated Vaccines Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Merck Live Attenuated Vaccines Product
Table 57. Merck Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Live Attenuated Vaccines Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Astellas Pharma Corporation Information
Table 64. Astellas Pharma Description and Business Overview
Table 65. Astellas Pharma Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Astellas Pharma Live Attenuated Vaccines Product
Table 67. Astellas Pharma Recent Developments/Updates
Table 68. Johnson & Johnson Corporation Information
Table 69. Johnson & Johnson Description and Business Overview
Table 70. Johnson & Johnson Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Johnson & Johnson Live Attenuated Vaccines Product
Table 72. Johnson & Johnson Recent Developments/Updates
Table 73. CSL Corporation Information
Table 74. CSL Description and Business Overview
Table 75. CSL Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. CSL Live Attenuated Vaccines Product
Table 77. CSL Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Sanofi Live Attenuated Vaccines Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Serum Institute Of India Corporation Information
Table 84. Serum Institute Of India Description and Business Overview
Table 85. Serum Institute Of India Live Attenuated Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Serum Institute Of India Live Attenuated Vaccines Product
Table 87. Serum Institute Of India Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Live Attenuated Vaccines Distributors List
Table 91. Live Attenuated Vaccines Customers List
Table 92. Live Attenuated Vaccines Market Trends
Table 93. Live Attenuated Vaccines Growth Drivers
Table 94. Live Attenuated Vaccines Market Challenges
Table 95. Live Attenuated Vaccines Market Restraints
Table 96. Global Live Attenuated Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 97. Global Live Attenuated Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Live Attenuated Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Live Attenuated Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Live Attenuated Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 101. Global Live Attenuated Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Live Attenuated Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Live Attenuated Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Live Attenuated Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 105. Global Live Attenuated Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Live Attenuated Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Live Attenuated Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Live Attenuated Vaccines
Figure 2. Global Live Attenuated Vaccines Market Share by Type in 2020 & 2027
Figure 3. Bacterial Product Picture
Figure 4. Viral Product Picture
Figure 5. Global Live Attenuated Vaccines Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Research Institutes
Figure 9. Others
Figure 10. Global Live Attenuated Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Live Attenuated Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Live Attenuated Vaccines Sales 2016-2027 (K Units)
Figure 13. Global Live Attenuated Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Live Attenuated Vaccines Sales Share by Manufacturers in 2020
Figure 15. Global Live Attenuated Vaccines Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Live Attenuated Vaccines Players: Market Share by Revenue in 2020
Figure 17. Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Live Attenuated Vaccines Sales Market Share by Region (2016-2021)
Figure 19. Global Live Attenuated Vaccines Sales Market Share by Region in 2020
Figure 20. Global Live Attenuated Vaccines Revenue Market Share by Region (2016-2021)
Figure 21. Global Live Attenuated Vaccines Revenue Market Share by Region in 2020
Figure 22. U.S. Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Live Attenuated Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Live Attenuated Vaccines by Type (2016-2021)
Figure 47. Sales Market Share of Live Attenuated Vaccines by Application (2016-2021)
Figure 48. Sales Market Share of Live Attenuated Vaccines by Application in 2020
Figure 49. Revenue Share of Live Attenuated Vaccines by Application (2016-2021)
Figure 50. Revenue Share of Live Attenuated Vaccines by Application in 2020
Figure 51. Manufacturing Cost Structure of Live Attenuated Vaccines
Figure 52. Manufacturing Process Analysis of Live Attenuated Vaccines
Figure 53. Live Attenuated Vaccines Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
